Literature DB >> 17942197

Developments in influenza vaccination coverage in England, Scotland and Wales covering five consecutive seasons from 2001 to 2006.

Majbrit V Holm1, Patricia R Blank, Thomas D Szucs.   

Abstract

This study aims at assessing trends in influenza vaccination coverage from 2001 to 2006 in Great Britain, at understanding drivers and barriers to vaccination and at identifying vaccination intentions for influenza season 2006/2007. In seasons 2001/2002 to 2005/2006, telephone-based household surveys representative of the population from age 16 were conducted, with about 2000 interviews per season (10,095 in total). Overall influenza vaccination coverage rate in Great Britain reached 25.9% in season 2005/2006. A sub-analysis showed that the highest coverage was reported in Wales reaching 33.3%. In the elderly recommended vaccination (from age 65), the coverage reached 79% in 2005/2006. Advice from the family doctor and the perception that influenza is a serious illness were the most frequent reasons for getting vaccinated. The most frequent reasons for not getting vaccinated, in persons never vaccinated before, were that they had not considered immunisation or had not received a recommendation from their family doctor. Those vaccinated in the past but not in the current season said they had not thought about vaccination/forgot. A gap continues to exist between those with intention to get vaccinated and those actually vaccinated, indicating a potential to increase vaccination coverage rate in the future. Our study shows that stable vaccination coverage rates were observed from 2002 to 2006 in Great Britain. The coverage had increased in Wales and in Scotland. The coverage among the elderly above 65 years was the highest in Europe. Although Great Britain complies with national and international goals of vaccination coverage rates effort is needed to ensure high vaccination coverage rates at the same level in the future.

Entities:  

Mesh:

Year:  2007        PMID: 17942197     DOI: 10.1016/j.vaccine.2007.09.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China.

Authors:  Li Zhang; Wim van der Hoek; Thomas Krafft; Eva Pilot; Liselotte van Asten; Ge Lin; Shuangsheng Wu; Wei Duan; Peng Yang; Quanyi Wang
Journal:  Hum Vaccin Immunother       Date:  2019-11-01       Impact factor: 3.452

Review 2.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2014-07-07

3.  Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons.

Authors:  P R Blank; M Schwenkglenks; T D Szucs
Journal:  Infection       Date:  2009-09-18       Impact factor: 3.553

4.  Factors associated with influenza vaccine uptake in older adults living in the community in Singapore.

Authors:  L W Ang; J Cutter; L James; K T Goh
Journal:  Epidemiol Infect       Date:  2016-12-08       Impact factor: 4.434

5.  Positive network assortativity of influenza vaccination at a high school: implications for outbreak risk and herd immunity.

Authors:  Victoria C Barclay; Timo Smieszek; Jianping He; Guohong Cao; Jeanette J Rainey; Hongjiang Gao; Amra Uzicanin; Marcel Salathé
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  Trends in influenza vaccination coverage in Portugal from 1998 to 2010: effect of major pandemic threats.

Authors:  Cátia Sousa Pinto; Baltazar Nunes; Maria João Branco; José Marinho Falcão
Journal:  BMC Public Health       Date:  2013-12-05       Impact factor: 3.295

7.  Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in China by season (2009/10 to 2011/12).

Authors:  Lei Zhou; Qiru Su; Zhen Xu; Ao Feng; Hui Jin; Shiyuan Wang; Zijian Feng
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.